Dr. Reddy's Laboratories Limited (RDY) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Drug Manufacturers - Specialty & Generic उद्योग. कंपनी का मुख्यालय है Hyderabad, India. वर्तमान CEO हैं Erez Israeli.
RDY के पास है IPO तिथि 2001-04-11, 27,048 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NYSE, बाजार पूंजीकरण $10.93B.
Dr. Reddy's Laboratories Limited is an integrated pharmaceutical company headquartered in Hyderabad, India, operating globally across multiple therapeutic areas including gastroenterology, cardiology, diabetes, dermatology, oncology, and respiratory medicine. The company operates through four primary segments: Global Generics, which manufactures prescription and over-the-counter finished pharmaceuticals and biologics; Pharmaceutical Services and Active Ingredients, which produces active pharmaceutical ingredients, intermediates, and contract research services; Proprietary Products, focused on differentiated formulation development; and Others, dedicated to oncology and inflammation therapies. With a strong presence in generic and branded pharmaceuticals worldwide, Dr. Reddy's has established strategic partnerships, including a collaboration with Curis, Inc. for immuno-oncology and precision oncology development. Founded in 1984, the company continues to expand its portfolio across developed and emerging markets.
